"pharmacy" via Stockport Education Centre Library
Area: Other Library Updates > Drug Alerts
Dear Healthcare Professional, Lincoln Medical Limited Anapen 500 micrograms in 0.3ml solution for injection in a pre - filled syringe PL 18813/0003 Anapen 300 micrograms in 0.3ml solution for injection in a pre - filled syringe PL 18813/0001 Anapen Junior 150 micrograms in 0.3ml solution for injection in a pre - filled syringe (Adrenaline (Epinephrine) autoinjector) PL 18813/0002 Lincoln Medical Limited is recalling all unexpired units of the above products to patient level as a precaution. This is because a potential problem with delivery time and delivery volume of the dosage following activation of the autoinjector has been identified during development work. In the worst case scenario, this could result in a failure to deliver any adrenaline at all in an emergency situation. The Company has informed us that they have received no defect or ADR reports from the market which may be associated with ...
Area: Other Library Updates > Drug Alerts
Kappin Limited Fulsovin 125mg/5ml Oral Suspension (Griseofulvin) PL 20249/0009 Kappin Limited is recalling all remaining stock of the above product because stability testing has indicated that the product will not comply with the required specifications for the duration of the shelf-life. Remaining stocks of this product should be quarantined and returned to the original supplier for credit. Kappin will not be releasing any further batches of this product until the stability issue is resolved. We are aware that there is no alternative treatment for some paediatric indications. Should you receive a prescription for this medicine whilst the UK licensed product is unavailable, we understand that Grisoefulvin 125mg/5ml Oral Suspension can be obtained as an unlicensed 'special' to meet the special needs of an individual patient. Please note: Pharmacists should seek assurances that product ...
Area: Other Library Updates > Drug Alerts
Dear Healthcare Professional, TEVA UK LIMITED Levothyroxine 100mcg Tablets in Teva UK and Numark liveries PL 00289/0039 Teva UK Limited is recalling all remaining in-date stock of the above product. The marketing authorisation was suspended in February 2012 and the supply position was then too fragile to permit a recall. Adequate supplies of alternative Levothyroxine 100 mcg tablets are now available which allows a recall of the remaining Teva UK and Numark branded product. This recall is restricted to the 100mcg strength only of these presentations. No other strengths or brands are included in the scope of the recall. Remaining stocks of these products should be returned to the original wholesaler for credit. For further stock enquiries please contact Teva UK Customer Liaison Team on 0800 590502. For medical information enquiries please contact Teva UK Limited by phone on 0207 540 7117 or ...
The quantity of medicines that is ‘wasted’ remains an area of concern for all those involved in healthcare. An estimated £450m worth of prescription medicines are discarded every year in England, Scotland, Wales and Northern Ireland.1–3 It is thought that a fifth of the population has one or more unused medicines in their possession, and that on average, 75 prescription items are returned to each community pharmacy every month.1 Nationally, around 1% of dispensed items are eventually returned to a pharmacy or dispensing GP practice unused or partially used.1 The national health services pay for medicines to be dispensed and then pay for those that have been returned to be collected and destroyed. Patients, relatives and carers are always dismayed to discover that returned medicines cannot be recycled for use by another patient. And if not in this country,...
Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers' attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned. We also include comments on, for example, the strengths of the information, whether it contains anomalies, ambiguities, apparent error or omissions, or whether or how it affects current practice.
In the UK, over 50% of adults are overweight (body mass index [BMI] of 25–29.9kg/m2) or obese (BMI 30kg/m2 or more); it is thought that over half of the UK population could be obese by 2050 because of the increasing availability of calorie-dense food and sedentary lifestyles.1–3 Interventions to achieve weight loss include diets, increased physical activity, behavioural modification strategies, drugs (e.g. orlistat) and bariatric surgery.4 Dietary interventions include low-calorie diets (LCDs; 1,000–1,200kcal/day for women and 1,200–1,600kcal/day for men), very low calorie diets (VLCDs; including Very Low Energy Diets [VLED]; below 800kcal/day) and Low Energy Liquid formula diets (LELD; above 800kcal/day).4,5 However, drop-out rates from such interventions are often high. Here we consider the safety and effectiveness of VLCDs and practical issues about their use.
Indacaterol powder for inhalation (Onbrez Breezhaler – Novartis) is a long-acting beta2 agonist, licensed for once-daily use as maintenance bronchodilator therapy for chronic obstructive pulmonary disease (COPD). In this article, we consider the evidence for indacaterol and how its use fits with current management strategies for COPD.
Area: Other Library Updates > Drug Alerts
Sanofi Priadel Liquid PL 04425/0354 (Lithium Citrate 520mg/5ml equivalent to Lithium Carbonate 204mg/5ml) Batch Number Expiry Date Pack Size First Distributed 31 Jan 2014 150ml 02 Apr 2012 32 Apr 2014 ...
Area: Other Library Updates > Drug Alerts
Special Products Ltd Epistatus, Midazolam 10mg in 1ml Buccal Liquid x 5ml (M11) Five New batches with 1.0 ml syringes to be distributed Unlicensed medicine made under Manufacturers Specials licence MS 123. Five new batches with 1.0 ml syringes to be distributed Batch number Expiry date Expected distribution date 28996 March 2014 April 2012 28977 TBC April 2012 ...
